Clinical Gastroenterology and Hepatology |
Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases |
fév. 17 |
3 ♥ |
MICI |
Internal Medecine |
Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion |
nov. 15 |
3 ♥ |
Endoscopie/Imagerie, Œsophage/Estomac, Cancers autres |
World Journal of Gastrointestinal Pharmacology and Theapeutics |
Massive duodenal variceal bleed; complication of extra hepatic portal hypertension: Endoscopic management and literature review |
déc. 15 |
3 ♥ |
Endoscopie/Imagerie |
Digestive and Liver Disease |
Comparison of the prognostic influence of emergency hepatectomy and staged hepatectomy in patients with ruptured hepatocellular carcinoma |
aoû. 16 |
1 ♥ |
Carcinome hépatocellulaire (CHC), Chirurgie |
Digestive and Liver Disease |
Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience |
avr. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma |
aoû. 16 |
2 ♥ |
Carcinome hépatocellulaire (CHC), Endoscopie/Imagerie |
Digestive and Liver Disease |
Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature |
avr. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Digestive and Liver Disease |
Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH) |
fév. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
High-grade anal intraepithelial neoplasia: Progression to invasive cancer is not a certainty |
juil. 16 |
1 ♥ |
Coloproctologie, Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014 |
mai. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
A study of the association between UGT1A1*28 variant allele of UGT1A1 gene and colonic phenotype of sporadic colorectal cancer |
avr. 19 |
1 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Risk of cancer in small and diminutive colorectal polyps |
juin. 16 |
|
Cancer colorectal (CCR) |
Digestive and Liver Disease |
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis. |
mai. 16 |
2 ♥ |
Carcinome hépatocellulaire (CHC) |
Digestive and Liver Disease |
Clinical outcome after biliary drainage for metastatic colorectal cancer: Survival analysis and prognostic factors |
fév. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Early metabolic response to chemoradiotherapy by interim FDG PET/CT is associated with better overall survival and histological response in esophageal cancers |
juin. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia |
avr. 19 |
1 ♥ |
Cancer colorectal (CCR), Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer |
Jan. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Characteristics and consequences of missed gastric cancer: A multicentric cohort study |
juin. 19 |
1 ♥ |
Cancers autres |
Digestive and Liver Disease |
Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France |
mar. 17 |
3 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases? |
oct. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |